197 related articles for article (PubMed ID: 21546960)
1. Auctioning the cure.
Willyard C
Nat Med; 2011 May; 17(5):528-30. PubMed ID: 21546960
[No Abstract] [Full Text] [Related]
2. Biotech patents-business as usual?
Lawrence S
Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
[No Abstract] [Full Text] [Related]
3. Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP; Deng MM
Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
[No Abstract] [Full Text] [Related]
4. Putting your best mode forward.
Tsao YR; Tabtiang RK
Nat Biotechnol; 2000 Oct; 18(10):1113-4. PubMed ID: 11017054
[No Abstract] [Full Text] [Related]
5. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
6. Intellectual property. Fixing the legal framework for pharmaceutical research.
Knowles SM
Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
[No Abstract] [Full Text] [Related]
7. Intellectual property and its role in the pharmaceutical industry.
Atkinson JD; Jones R
Future Med Chem; 2009 Dec; 1(9):1547-50. PubMed ID: 21425976
[No Abstract] [Full Text] [Related]
8. Industrial health research in Canada.
Morin Y
CMAJ; 2007 Jun; 176(12):1734; author reply 1734. PubMed ID: 17548390
[No Abstract] [Full Text] [Related]
9. Big companies helped by safe harbour ruling.
Frantz S
Nat Rev Drug Discov; 2005 Jul; 4(7):525-6. PubMed ID: 16075481
[No Abstract] [Full Text] [Related]
10. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
Buckely M
Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
[No Abstract] [Full Text] [Related]
11. Biotech in post-TRIPS India.
Ramani SV; Pradhan P; Ravi M
Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
[No Abstract] [Full Text] [Related]
12. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
Trask AV
Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
[No Abstract] [Full Text] [Related]
13. The role of the private sector in biotechnology: research and development.
Feisee L
Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
[No Abstract] [Full Text] [Related]
14. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
15. China tightens IP protection, but concerns linger.
Jia H
Nat Biotechnol; 2009 Sep; 27(9):787-8. PubMed ID: 19741619
[No Abstract] [Full Text] [Related]
16. Sitting up and taking notice.
Nat Biotechnol; 2010 May; 28(5):381. PubMed ID: 20458284
[No Abstract] [Full Text] [Related]
17. Patent fight sparks biological warfare in the drug industry.
Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
[No Abstract] [Full Text] [Related]
18. Patent watch: Drug patenting in India: looking back and looking forward.
Sampat BN; Shadlen KC
Nat Rev Drug Discov; 2015 Aug; 14(8):519-20. PubMed ID: 26184492
[No Abstract] [Full Text] [Related]
19. Biotech battle royale. Two firms fight over billion-dollar drug.
Sherrid P
US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209
[No Abstract] [Full Text] [Related]
20. Conflicts brewing as phage display gets complex.
Glaser V
Nat Biotechnol; 1997 Jun; 15(6):506. PubMed ID: 9181564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
